Trump’s prescription drug executive order rollback didn’t quash all Biden-backed cost savings
The executive order, which Biden signed in October 2022, had not spurred any lower drug prices by the time Trump revoked it Jan. 20. The order directed the Health and Human Services Department secretary to consider "new health care payment and delivery models" for the Center for Medicare and Medicaid Innovation to test.
Medicare will soon negotiate prices for 15 more drugs as part of an effort to reduce costs for seniors and people with ...
The directive for the Department of Health and Human Services to develop and test new models aimed at lowering drug costs ...
The hugely popular medications Ozempic and Wegovy​, used for diabetes and weight loss, will be included in the next round of ...
On its last weekday in power, the Biden Administration has chosen the next batch of drugs up for price negotiation in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback